Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request